ClinicalTrials.gov record

Completed No phase listed Observational Accepts healthy volunteers Results available

Novapak Prospective Observational Clinical Trial

ClinicalTrials.gov ID: NCT05747014

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05747014. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Novapak study is a prospective, observational, multi-site, non-controlled, non-randomized, case-series, with a 2 week and 1-month follow-up in adults undergoing nasal/sinus surgery with Novapak Nasal Sinus Packing and Stent device used as indicated post-operatively and is being conducted to obtain clinical data on the safety and effectiveness of the Novapak device under use as intended in the device indications.

Study identification

NCT ID: NCT05747014
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Medtronic Surgical Technologies; Industry
Enrollment: 86 participants

Conditions and interventions

Conditions

Nasal Airway Obstruction

Interventions

Novapak Nasal Sinus Packing and Stent Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 9, 2023 (Actual)
Primary completion: Dec 13, 2023 (Actual)
Completion: Dec 13, 2023 (Actual)
Last update posted: Nov 21, 2024

2023

United States locations

U.S. sites: 3
U.S. states: 1
U.S. cities: 3

Facility	City	State	ZIP	Site status
ENT Associates of South Florida	Boca Raton	Florida	33487	—
University of Miami	Miami	Florida	33136	—
University of South Florida	Tampa	Florida	33612	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05747014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 21, 2024 · Synced Nov 15, 2026